Summit Street Capital Management, LLC United Therapeutics Corp Transaction History
Summit Street Capital Management, LLC
- $280 Million
- Q3 2024
A detailed history of Summit Street Capital Management, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Summit Street Capital Management, LLC holds 36,431 shares of UTHR stock, worth $13.1 Million. This represents 4.66% of its overall portfolio holdings.
Number of Shares
36,431
Previous 36,431
-0.0%
Holding current value
$13.1 Million
Previous $11.6 Million
12.49%
% of portfolio
4.66%
Previous 4.24%
Shares
14 transactions
Others Institutions Holding UTHR
# of Institutions
671Shares Held
42.3MCall Options Held
194KPut Options Held
295K-
Black Rock Inc. New York, NY5.47MShares$1.97 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$1.59 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.17MShares$1.14 Billion0.2% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1.03 Billion15.42% of portfolio
-
State Street Corp Boston, MA2.24MShares$808 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16.4B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...